<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

Oncology

Faculty    Cancer    Pharmacy    Oncology

Oncology Pharmacists Share Cancer Expertise in Nigeria

NOTE: This article originally appeared in Pharmacy Practice News; Dave Doolittle, writer.

Cindy O’Bryant, PharmD, didn’t know quite what to expect in the days leading up to a trip to Nigeria late last year that was designed to help strengthen cancer treatment and care in the African nation. Although she has met several Nigerian healthcare professionals and students as a clinical pharmacy professor at the University of Colorado Anschutz Skaggs School of Pharmacy and Pharmaceutical Sciences she had no first-hand knowledge of how her colleagues there treated cancer patients.


Author Guest Contributor | Publish Date May 03, 2022
Full Story

Pharmacy    Oncology

Fulbright Sends O'Bryant to Nigeria

Dr. Cindy O’Bryant, PharmD, Professor in the Department of Clinical Pharmacy, received a Fulbright Specialist Program Scholar Award. A program of the U.S. Department of State, the Fulbright Specialist Program is a unique opportunity for U.S. academics and established professionals to engage in two to six-week, project-based exchanges at host institutions across the globe. On November 27, Dr. O’Bryant left the U.S. for Nigeria with other oncology pharmacists to share her knowledge and experience in cancer care to advance pharmacy oncology practice. She made time to answer questions before her trip about her award, what she expects from the field, and what she hopes to share with medical professionals in Nigeria.


Author Jordan Kellerman | Publish Date December 01, 2021
Full Story

School of Pharmacy In the News

Medscape

Time to Test Effects of CBD in Cardiovascular Disease?

news outletMedscape
Publish DateOctober 05, 2022

Robert Page, PharmD, weighs in on the need for well-designed clinical trials to test the safety and efficacy of cannabidiol (CBD) for cardiovascular disease, based on evidence from preclinical studies showing that it has anti-inflammatory effects.

Full Story
Health.com

Cooking Chicken in NyQuil Is a 'Recipe for Danger' FDA Warns, Citing TikTok Video

news outletHealth.com
Publish DateSeptember 22, 2022

Dr. Gina Moore, PharmD, MBA, talks with Health on why this viral TikTok trend is a dangerous misuse of medication.

Full Story
ScienceDaily

Early intervention effective in treating neurodevelopmental disorders

news outletScienceDaily
Publish DateSeptember 07, 2022

A new study from Molly, Huntsman, PhD, suggests that therapeutic interventions to treat neurodevelopmental disorders may be more effective if done during the early stages of brain development.

Full Story
Cancer Health

Lipid Nanoparticles Show Significant Promise in Carrying Cancer Drugs to Tumors

news outletCancer Health
Publish DateSeptember 02, 2022

CU Pharmacy and Cancer Center researcher Dmitri Simberg, PhD, is focusing on penetrating the blood-brain barrier in glioblastoma to more effectively deliver anti-cancer therapies.

Full Story